Detalhe da pesquisa
1.
Empty pelvis syndrome: a retrospective audit from a tertiary cancer center.
Langenbecks Arch Surg
; 408(1): 331, 2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615748
2.
Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and 'salvage' in patients with high risk locally advanced rectal cancers - tolerance and early outcomes.
J Cancer Res Ther
; 20(1): 199-203, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554321
3.
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.
Eur J Cancer
; 200: 113560, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306841
4.
Real-world analysis of the use of lenvatinib in differentiated thyroid cancers.
Ecancermedicalscience
; 17: 1500, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36816785
5.
Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer.
Lancet Reg Health Southeast Asia
; 12: 100143, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37384062
6.
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.
J Clin Oncol
; 41(2): 222-232, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265101
7.
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.
J Clin Oncol
; 41(13): 2350-2361, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706347
8.
A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study).
Med Oncol
; 40(1): 17, 2022 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372825
9.
Audit of screen failure in 15 randomised studies from a low and middle-income country.
Ecancermedicalscience
; 16: 1476, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819805
10.
Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial.
EClinicalMedicine
; 49: 101449, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747192
11.
Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Variant Lung Cancer-Long-Term Results of a Randomized Clinical Trial.
JAMA Oncol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662354